Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C.   Oliver R.T.D.   Gallagher C.J.   J. O.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

Bevacizumab Plus Irinotecan–Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

By Yildiz Ramazan   Buyukberber Suleyman   Uner Aytug   Yamac Deniz   Coskun Ugur   Kaya Ali Osman   Ozturk Banu   Yaman Emel   Benekli Mustafa  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 33-37

Informa Healthcare

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens

By                    

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 241-245

Spandidos Publications

Access to resources Recommend Favorite

Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy

By          

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 905-909

Spandidos Publications

Access to resources Recommend Favorite